CHDI is delighted to announce that registration is now open for the 17th Annual HD Therapeutics Conference to be held February 28 through March 3, 2022, in Palm Springs, California. We will continue to monitor developments around the Omicron variant and respond accordingly if warranted, but our vital collaborative work together to develop therapeutics that will substantially improve the lives of people with HD must go on. We will use all the available tools and practices—including being outdoors at the beautiful Parker Hotel—to make next year’s HDTC a safe, enjoyable, and productive gathering.
We are putting together a conference program that will cover all aspects of HD drug development, including current and future biomarkers, novel HD therapeutic approaches, the new HD Integrated Staging System, updates on clinical trials including GENERATION HD1, and other presentations informing our understanding of HD pathophysiology.